Noteworthy, serum semaphorin 3F levels in patients with preeclampsia were comparable to those of non-pregnant health female controls (n = 40) (2.01±0.33 vs. 1.70±0.30 ng/mL, p = 0.07) (Fig 3A). This evidence concerns the gene SEMA3F and preeclampsia.